Center-Authored Papers

Filters: Author is Gralow, Julie R  [Clear All Filters]
2008
Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow JR, Hortobagyi GN, Livingston R.  2008.  A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5. Abstract
Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B et al..  2008.  Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(5):814-9. Abstract
Gralow JR, Zujewski JA, Winer E.  2008.  Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(5):696-7.
Syrjala KL, Abrams JR, Polissar NL, Hansberry J, Robison J, DuPen S, Stillman M, Fredrickson M, Rivkin S, Feldman E et al..  2008.  Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial.. Pain. 135(1-2):175-86. Abstract
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow JR.  2008.  Major depression after breast cancer: a review of epidemiology and treatment.. General hospital psychiatry. 30(2):112-26. Abstract
Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow JR et al..  2008.  Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(28):4672-8. Abstract
Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF et al..  2008.  Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(27):4449-57. Abstract
2009
Gralow JR, Biermann SJ, Farooki A, Fornier MN, Gagel RF, Kumar RN, Shapiro CL, Shields A, Smith MR, Srinivas S et al..  2009.  NCCN Task Force Report: Bone Health in Cancer Care.. Journal of the National Comprehensive Cancer Network : JNCCN. 7 Suppl 3:S1-S32;quizS33-S35. Abstract
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP et al..  2009.  Adjuvant chemotherapy in older women with early-stage breast cancer.. The New England journal of medicine. 360(20):2055-65. Abstract
Specht J, Gralow JR.  2009.  Neoadjuvant chemotherapy for locally advanced breast cancer.. Seminars in radiation oncology. 19(4):222-8. Abstract
2010
Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, Mankoff DA.  2010.  Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 51(4):521-7. Abstract
Albain KS, Carey L, Gradishar WJ, Gralow JR, Lipton A, Rugo H, Tripathy D, Peck S, Abair T, Pegram M.  2010.  Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.. Clinical breast cancer. 10(6):421-39. Abstract
Jensen MP, Chang H-Y, Lai Y-H, Syrjala KL, Fann JR, Gralow JR.  2010.  Pain in long-term breast cancer survivors: frequency, severity, and impact.. Pain medicine (Malden, Mass.). 11(7):1099-106. Abstract
Specht JM, Kurland BF, Montgomery SK, Dunnwald LK, Doot RK, Gralow JR, Ellis GK, Linden HM, Livingston RB, Allison KH et al..  2010.  Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(10):2803-10. Abstract
2011
El Saghir NS, Adebamowo CA, Anderson BO, Carlson RW, Bird PA, Corbex M, Badwe RA, Bushnaq MA, Eniu A, Gralow JR et al..  2011.  Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S3-11. Abstract
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Dunnwald LK, Doot RK, Specht JM, Gralow JR, Ellis GK, Livingston RB, Linden HM, Gadi VK, Kurland BF, Schubert EK et al..  2011.  PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(8):2400-9. Abstract
Linden HM, Kurland BF, Peterson LM, Schubert EK, Gralow JR, Specht JM, Ellis GK, Lawton TJ, Livingston RB, Petra PH et al..  2011.  Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(14):4799-805. Abstract
Gralow JR, Lipton A, Stopeck AT.  2011.  How Do We Define Efficacy in Comparing Osteoclast-Targeted Agents in Metastatic Breast Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3591-3592.
2012
Jensen MP, Gralow JR, Braden A, Gertz KJ, Fann JR, Syrjala KL.  2012.  Hypnosis for symptom management in women with breast cancer: a pilot study.. The International journal of clinical and experimental hypnosis. 60(2):135-59. Abstract
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB et al..  2012.  Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44. Abstract
2013
Thariani R, Henry NL, Ramsey SD, Blough DK, Barlow B, Gralow JR, Veenstra DL.  2013.  Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis Journal of Comparative Effectiveness Research. 2(3):325-334.
Gralow JR, Biermann SJ, Farooki A, Fornier MN, Gagel RF, Kumar R, Litsas G, McKay R, Podoloff DA, Srinivas S et al..  2013.  NCCN Task Force Report: Bone Health in Cancer Care.. Journal of the National Comprehensive Cancer Network : JNCCN. 11 Suppl 3:S1-S50. Abstract
Zirpoli GR, Brennan PM, Hong C-C, McCann SE, Ciupak G, Davis W, Unger JM, Thomas Budd G, Hershman DL, Moore HCF et al..  2013.  Supplement use during an intergroup clinical trial for breast cancer (S0221).. Breast cancer research and treatment. 137(3):903-13. Abstract
Koon KP, Lehman CD, Gralow JR.  2013.  The importance of survivors and partners in improving breast cancer outcomes in Uganda.. Breast (Edinburgh, Scotland). Abstract